Related Experiment Video
Updated: Feb 16, 2026

Antimicrobial Synergy Testing by the Inkjet Printer-assisted Automated Checkerboard Array and the Manual Time-kill Method
Published on: April 18, 2019
Carbapenem Resistance: A Review
Francis S Codjoe1,2, Eric S Donkor3
1Department of Medical Laboratory Sciences (Microbiology Division), School of Biomedical & Allied Health Sciences, College of Health Sciences, University of Ghana, Korle Bu KB 143 Accra, Ghana. fscodjoe@chs.edu.gh.
Abstract:
Carbapenem resistance is a major and an on-going public health problem globally. It occurs mainly among Gram-negative pathogens such as Klebsiella pneumoniae, Pseudomonas aeruginosa and Acinetobacter baumannii, and may be intrinsic or mediated by transferable carbapenemase-encoding genes. This type of resistance genes are already widespread in certain parts of the world, particularly Europe, Asia and South America, while the situation in other places such as sub-Saharan Africa is not well documented. In this paper, we provide an in-depth review of carbapenem resistance providing up-to-date information on the subject.
Insights
Carbapenem resistance is a global health threat, primarily affecting Gram-negative bacteria. This review details carbapenem resistance mechanisms and worldwide distribution, highlighting data gaps in regions like sub-Saharan Africa.
Area of Science:
- Microbiology
- Infectious Diseases
- Public Health
Background:
- Carbapenem resistance poses a significant global public health challenge.
- It is prevalent in Gram-negative pathogens, including Klebsiella pneumoniae, Pseudomonas aeruginosa, and Acinetobacter baumannii.
- Resistance can be intrinsic or acquired through transferable carbapenemase-encoding genes.
Purpose of the Study:
- To provide an in-depth review of carbapenem resistance.
- To offer up-to-date information on carbapenem resistance mechanisms and epidemiology.
- To highlight geographical variations in carbapenem resistance, noting under-documented regions.
Main Methods:
- Literature review of carbapenem resistance.
- Synthesis of current data on resistance mechanisms.
- Analysis of global distribution patterns of carbapenemase-encoding genes.
Main Results:
- Carbapenem resistance is widespread globally, particularly in Europe, Asia, and South America.
- Gram-negative pathogens are the primary carriers of carbapenem resistance.
- The prevalence and documentation of carbapenem resistance in sub-Saharan Africa require further investigation.
Conclusions:
- Carbapenem resistance is a critical and evolving public health issue.
- Understanding the epidemiology and mechanisms of carbapenem resistance is crucial for effective control.
- Further research is needed to fully characterize carbapenem resistance in under-documented geographical areas.
More Related Videos
Related Concept Videos
Development of Antibiotic Resistance
Antimicrobial Effectiveness
Antibiotic Selection
Treatment Resistant Cancers

